AI 처방전 준수 도구

집

AI 프롬프트 목록

의료 건강

처방전 감사 어시스턴트

${:__('collect %s',처방전 감사 어시스턴트)}$

의료 건강

임상 지침에 따라 처방전을 자동으로 감사하고, 상호작용 및 용량 이상을 식별하여 표준화된 위험 보고서를 생성합니다.

프롬프트 내용

복사

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract drug names, dosages, routes, and frequencies, cross-referencing them with the patient's current diagnosis, allergy history, and renal/hepatic function. Focus on identifying potential drug-drug interactions, contraindications, and overdose risks, evaluating rationality based on the latest clinical guidelines. Finally, output the audit results in a structured list, clearly flagging high-risk items and providing specific adjustment suggestions or alternatives to ensure medication safety.

복사

제공된 환자의 처방전에 대한 준법성을 검토하기 위해 시니어 임상 약사 역할을 수행하세요. 먼저 약물명, 용량, 투여 경로 및 빈도를 추출하여 환자의 현재 진단, 알레르기 이력, 간신기능과 대조하십시오. 잠재적인 약물 상호작용, 금기 사항 및 과다 복용 위험 식별에 중점을 두고 최신 임상 지침에 따라 타당성을 평가하십시오. 마지막으로, 구조화된 목록 형식으로 감사 결과를 출력하고, 고위험 항목을 명확히 표시하며, 구체적인 조정 제안 또는 대체안을 제공하여 약물 안전성을 보장하십시오.

복사

공유 링크를 복사하려면 클릭

의견 (0)

0/300

제출하다

추천

처방전 감사 어시스턴트

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Consider the patient's age, liver/kidney function, and allergy history to highlight potential risks and provide optimization suggestions, ensuring the treatment plan aligns with the latest clinical guidelines and medication standards.

처방 감사 어시스턴트

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and whether dosages align with the patient's hepatic and renal function status. Provide adjustment suggestions or risk warnings based on the latest clinical guidelines to ensure the safety and efficacy of the medication regimen.

처방전 감사 어시스턴트

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male with a history of hypertension and mild renal insufficiency. The current prescription includes Amoxicillin, Amlodipine, and Ibuprofen. Focus on analyzing the potential interactions between Ibuprofen and existing underlying conditions or antihypertensive drugs, assess the impact of renal insufficiency on drug metabolism, and point out any risks of duplicate therapy or overdosing. Finally, provide adjustment recommendations.

처방전 감사 어시스턴트

Act as a senior clinical pharmacist to conduct a comprehensive review of the provided patient prescription data. First, extract key patient demographics, diagnosis, and all prescribed medications with their respective dosages. Second, cross-reference these details against current clinical guidelines and drug monographs to identify potential drug-drug interactions, contraindications, and dosage appropriateness relative to the patient's renal or hepatic function. Third, evaluate the rationale for any off-label uses and assess potential adverse effects. Finally, present your findings in a structured list, highlighting any safety concerns, recommended dosage adjustments, or areas requiring further clinical verification, ensuring the output is actionable and prioritizes patient safety.

처방전 감사 어시스턴트

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, contraindication matching, and dosage appropriateness. Cross-reference with the patient's medical history and allergy records to flag any potential risks and provide optimization suggestions aligned with the latest clinical guidelines, ensuring the safety and efficacy of the medication regimen.

처방전 심사 보조

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, checking for incompatibilities, verifying if dosages align with the patient's age and renal/hepatic function, and ensuring no contraindications are violated. List all identified risks and provide optimization suggestions or alternatives based on the latest clinical guidelines to ensure medication safety and regulatory compliance.